State AIDS Drug Assistance Programs Continue to Face Difficult Funding Challenges; 11 States Close Enrollment, 9 Have Waiting Lists to Receive HIV Drugs; Wide Variation in Access to HIV

May 2004
Ascribe Newswire: Medicine;5/20/2004, p165
Despite a 9 percent increase in the overall AIDS Drug Assistance Programs (ADAPs) budget in the U.S. between fiscal year 2002 and 2003, an increasing number of people living longer with HIV/AIDS, the rising costs of HIV medications, and continuing fiscal pressures at the Federal and state levels have led some state ADAPs to implement cost-saving measures such as capping enrollment and reducing the number of HIV-medications offered. ADAPs continue to be in a difficult situation with the need for HIV/AIDS medications exceeding available resources, said Jennifer Kates, M.A., M.P.A, Director of HIV Policy, Kaiser Family Foundation.


Related Articles

  • Estimated HIV Infection and Reported AIDS Cases, 2007.  // World Almanac & Book of Facts;2009, p1038 

    An encyclopedia entry about human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) cases in 2007 is presented. The estimated number of new HIV infection was 2.7 million in 2007, while there were two million AIDS-related deaths in the same year. About half of the global...

  • Bridging The Resource Gap: Improving Value For Money In HIV/AIDS Treatment. Soni, Anil; Gupta, Rajat // Health Affairs;Nov/Dec2009, Vol. 28 Issue 6, p1617 

    The world faces both near-term and potentially long-term shortfalls in funding for HIV/AIDS care and treatment. We review the current funding environment, then discuss a range of opportunities to optimize spending on HIV/AIDS. These include (but are not limited to) more use of specific...

  • Coping with the cost burdens of illness: Combining qualitative and quantitative methods in longitudinal, household research. Goudge, Jane; Gumede, Tebogo; Gilson, Lucy; Russell, Steve; Tollman, Stephen M.; Mills, Anne // Scandinavian Journal of Public Health;May2007 Supplement 69, Vol. 35 Issue s69, p181 

    Over the last 10-15 years, poor African households have had to cope with the burden of increased levels of chronic illness such as HIV/AIDS. How do these households cope with the cost burdens of ill health and healthcare, and has this burden further impoverished them? What policy responses might...

  • Analysis of Michigan Medicaid Costs to Treat HIV Infection. Solomon, David J.; Hogan, Andrew J.; Bouknight, Reynard A.; Solomon, Carolyn T. // Public Health Reports;Sep/Oct89, Vol. 104 Issue 5, p416 

    To obtain better understanding of the nature and cost of health care related to human immunodeficiency virus (HIV) infection, medical payment records were analyzed for 204 men, women, and children older than 60 months who had indications of HIV infection. The records were those of Michigan...

  • HIV patients live years after diagnosis.  // Gay & Lesbian Times;11/16/2006, Issue 986, p28 

    The article reports on the results of a research which show that an American diagnosed with the AIDS virus can expect to live for about 24 years on average. The research also shows that the cost of health care throughout those decades is more than $600,000. Bruce Schackman is the lead author of...

  • Cost effectiveness of prophylaxis for opportunistic infections in AIDS. An overview and methodological discussion. Freedberg, K.A.; Paltiel, A.D. // PharmacoEconomics;1998, Vol. 14 Issue 2, p165 

    Dramatic progress has recently been made in defining the pathogenesis and treatment of HIV infection. For the first time in the history of the AIDS epidemic, clinicians have at their disposal an understanding of the replication kinetics of HIV, reliable assays to measure viral load, an...

  • Even Drug-Resistant HIV Infection Responds to Right Treatment.  // Ascribe Newswire: Medicine;5/3/2004, p120 

    Once expected to die in early childhood, children born with HIV are now surviving into their teens and early adulthood thanks to research advances over the past decade. However, it's also likely these children will develop drug resistance due to sequential exposure to HIV treatments. Researchers...

  • Impact of Pill Sharing on Drug Resistance Due to a Wide-Scale Oral Prep Intervention in Generalized Epidemics. Dimitrov, Dobromir; Boily, Marie-Claude; Mâsse, Benoît R.; Brown, Elizabeth R. // Journal of AIDS & Clinical Research;Special2012, Vol. 3 Issue S, Special section p1 

    Background: The first antiretroviral drug (Truvada) to be used as a pre-exposure prophylaxis (PrEP) in preventing HIV transmission is about to be approved. Behavioral studies suggest that a portion of users may share anti-retroviral drugs with sex partners, family, or friends. Pill sharing will...

  • Ethical challenges posed by clinical progress in AIDS. Bayer, Ronald; Stryker, Jeff // American Journal of Public Health;Oct97, Vol. 87 Issue 10, p1599 

    The article comments on the ethical issues surrounding therapeutic advances in AIDS. Several researchers at the 11th International AIDS Conference held in Vancouver, British Columbia, presented evidence suggesting the possibility of dramatically reducing the viral load of HIV-infected...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics